Loading clinical trials...
Loading clinical trials...
Clozapine (Clz), an atypical antipsychotic, is the reference medication for patients with treatment-resistant schizophrenia. Due to the high inter-individual variability of its pharmacokinetics and it...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Monastir
NCT06634641 · Clozapine, Parkinson's Disease (PD), and more
NCT06610123 · CYP1A2 Polymorphism, Caffeine and Resistance Training
NCT07545382 · Anticholinergic Delirium, Clozapine Poisoning, and more
NCT01759485 · Clozapine Resistant Schizophrenia
NCT01045720 · Schizophrenia, Clozapine, and more
Faculty of Medecine of Monastir
Monastir
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions